Canova C R
Medizinische Klinik, Kantonsspital Chur.
Schweiz Med Wochenschr. 1996 Aug 17;126(33):1394-9.
The primary objective of antihypertensive treatment is to prevent the involvement of target-organs, including hypertensive vascular disease of the kidney or left ventricular hypertrophy. Antihypertensive treatment should not worsen other cardiovascular risk factors (e.g. lipids) or impair quality of life. Contemporary efforts to optimize antihypertensive therapy are focused on single-drug therapy and on individualizing treatment according to patients age, sex, race and the presence of concomitant illnesses and therapies, in order to improve compliance and reduce overall cardiovascular morbidity and mortality. Several antihypertensive drugs such as ACE-inhibitors, beta-adrenergic-receptor antagonists, calcium channel blockers, diuretics, alpha-adrenergic-receptor antagonists, and newer substances such as imidazoline-receptor antagonists and angiotensin-II antagonists are discussed.
抗高血压治疗的主要目标是预防靶器官受累,包括肾脏的高血压血管疾病或左心室肥厚。抗高血压治疗不应使其他心血管危险因素(如血脂)恶化或损害生活质量。当代优化抗高血压治疗的努力集中在单药治疗以及根据患者的年龄、性别、种族以及合并疾病和治疗情况进行个体化治疗,以提高依从性并降低总体心血管发病率和死亡率。文中讨论了几种抗高血压药物,如血管紧张素转换酶抑制剂、β-肾上腺素能受体拮抗剂、钙通道阻滞剂、利尿剂、α-肾上腺素能受体拮抗剂,以及较新的药物如咪唑啉受体拮抗剂和血管紧张素II拮抗剂。